Background: The aim of this study was to investigate the effect of treatment with the saliva biomimetic, casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and SnF 2 /NaF compared with SnF 2 /NaF alone on coronal surface caries progression in head-and-neck cancer patients undergoing radiotherapy. Methods: Twenty-four participants were randomized into two groups. Both groups used 0.4% SnF 2 gel and a 0.32% NaF toothpaste; the test group also applied a cr eme containing 10% CPP-ACP three times daily while the control group used an identical cr eme without CPP-ACP (placebo). Resting saliva flow rate and saliva fluoride concentrations were determined. Caries status was assessed using ICDASII at baseline and 12-weeks postradiotherapy. Data were statistically analysed using a linear mixed effects model. Results: Both groups showed significantly reduced resting saliva flow rate (P < 0.001) postradiotherapy. There were no significant differences in flow rates and fluoride concentration between groups. The CPP-ACP group exhibited a significant (P < 0.05) 51% reduction in coronal surface caries progression compared with the placebo group. Conclusion: Resting salivary flow rate was significantly reduced in head-and-neck cancer patients following radiotherapy and use of CPP-ACP with SnF 2 /NaF significantly lowered caries progression compared with SnF 2 /NaF alone.
INTRODUCTION
Globally, more than 550 000 new cases of head-andneck cancer are diagnosed each year. 1 In Singapore, the most common head-and-neck cancer, nasopharyngeal carcinoma (NPC), is the eighth most common cancer affecting Singapore males with an age-standardized incidence and mortality rates of 8.1 and 4.2 per 100 000 per year respectively. 2 Radiotherapy plays an important role in the treatment of the majority of head-and-neck cancer cases. 3, 4 Unfortunately, besides the therapeutic anti-cancer effect, the ionizing irradiation can also damage healthy tissues located in the radiation field, resulting in both acute and chronic adverse effects. Advanced radiotherapy techniques such as intensity-modulated radiotherapy (IMRT) improves tumour targeting with significant sparing of the surrounding healthy tissues. 5 Despite improved tumour control, significant adverse effects on oral health still occur as the oral cavity and the surrounding salivary glands are still within the irradiation field. 6 Sequelae such as xerostomia, radiation-related caries, osteoradionecrosis, trismus and dysphagia contribute to long-term emotional and physical trauma.
Radiotherapy changes the quantity, quality and composition of saliva, resulting in decreased salivary flow, buffering capacity, electrolyte and immunoprotein levels, oral clearance and an increase in acidity and levels of cariogenic bacteria. [7] [8] [9] [10] [11] [12] [13] This adversely affects the oral environment significantly increasing the risk of caries progression. Radiation-related caries is a highly destructive form of dental disease. 14, 15 It is characterized by rapid onset and progression and can be initiated at any part of the tooth surface, even on those surfaces that are normally less susceptible to the disease. 16, 17 Radiation-related caries can be clinically detected as early as a few months after completion of radiotherapy and progress rapidly within a short 
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The official journal of the Australian Dental Association period of time, resulting in coronal amputation of the teeth. 15 Extraction of teeth in the high dose fraction is associated with increased risk of postradiation osteonecrosis. 18, 19 In a systematic review analysis, the reported mean decayed, missing, filled teeth (DMFT) in postradiotherapy patients was 17.0 which was a four-fold increase compared with healthy controls. 20 In long-term head-and-neck cancer survivors, higher DMFT scores were associated with worse scores for various quality-of-life domains. 21 Radiation-related caries sequelae thus negatively influence the healthrelated quality of life of affected individuals.
For decades, the control of caries progression in head-and-neck cancer survivors has been managed through the life-long use of topical fluoride mouthrinses or 1.1% sodium fluoride (NaF) gel (5000 ppm F) application by means of a custom-made fluoride tray. 6, 22 In Singapore, where 5000 ppm F products are not available, the recommended protocol for caries prevention in these individuals is the application of 0.412% stannous fluoride (SnF 2 ) gel (1000 ppm fluoride) by means of a custom-made tray as well as the normal use of a 1450 ppm F dentifrice.
The use of fluoride oral care products is an important strategy in managing caries. 23 The anticariogenic mechanism of fluoride is the localization of fluoride ions at the tooth surface, particularly in the presence of calcium and phosphate ions. 24 This localization increases the degree of saturation with respect to fluorapatite, promoting the remineralization of enamel with fluorapatite, which is more acid resistant. Remineralization with fluorapatite [Ca 10 (PO 4 ) 6 F 2 ] is possible only when calcium and phosphate ions are co-localized with fluoride ions at the tooth surface. Hence, fluoride-driven remineralization is limited by the bioavailability of calcium ions [25] [26] [27] which would be exacerbated in irradiated head-and-neck cancer patients with saliva hypofunction.
Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), a stabilized source of bioavailable calcium and phosphate ions is a saliva biomimetic and has been shown to significantly reduce caries progression and enhance regression of early carious lesions in clinical studies on healthy individuals. 28, 29 Enhanced remineralizing activity was observed when fluoride in the form of NaF was added into the CPP-ACP complex. [30] [31] [32] Recently, SnF 2 has been shown to be superior to sodium fluoride in preventing enamel mineral dissolution by the formation of stannous fluorapatite barrier layer on the enamel surface. 33 The addition of CPP-ACP to an SnF 2 solution has been reported to promote greater remineralization of enamel subsurface lesions compared with a CPP-ACP/ NaF solution in an in situ study. 34 The aim of this clinical study was to investigate the adjunctive treatment of CPP-ACP with SnF 2 /NaF compared with SnF 2 /NaF alone on coronal surface caries progression in NPC patients after IMRT.
METHODS
The clinical study was a double-blind randomized placebo-controlled study and was approved by the Centralised Singapore Health Institutional Review Board (Approval No. 2010/182/D). The study is listed on the ISRCTN Registry (ISRCTN14942820) and was performed in accordance with the ethical standards of the Declaration of Helsinki (2013). All study participants were prescribed standard 0.412% SnF 2 (1000 ppm F) gel (Gel Kam â ; Colgate, New York, NY, USA) in a custom-made tray and 0.32% NaF (1450 ppm F) dentifrice (Colgate Total, Professional Clean, Colgate) for daily oral care and randomized to receive either a 10% w/w CPP-ACP cr eme or a placebo cr eme containing exactly the same constituents as the CPP-ACP cr eme except for CPP-ACP (GC Corporation, Tokyo, Japan). Randomization was carried out, based on a generated randomization list, after preradiotherapy oral health clearance where all necessary restorative work was completed. All participants and personnel involved in the study were blinded to the cr eme type as they were provided in coded tubes. The code was not released until after the completion of the study and data lock.
Twenty four study participants with a total of 2685 tooth surfaces at risk were recruited by CPCS from NPC patients referred to the National Dental Centre Singapore for preradiotherapy oral health clearance in 2010 (Fig. 1 ). The sample size was calculated using G Power version 3.1.9.2 sample size package 35 with an effect size of 0.15 estimated from data collected from a pilot study, with power of 0.9 and an a-value of 0.05 based on a two-tailed t-test. A sample size of nine patients per group was calculated. To account for patient withdrawal, the estimated sample size was increased by 20% to 11-12 patients per group and this was deemed suitable for the purpose of the study. Eligibility to participate in the study included the presence of at least 20 remaining teeth after oral health clearance and a participant age of at least 21 years. Individuals who had undergone head-andneck radiotherapy previously or were receiving palliative care were excluded. Written informed consent was obtained from the study participants.
Study participants were provided with a soft-textured toothbrush and 0.32% NaF dentifrice (Colgate Total) for daily oral care. They were instructed not to use any other fluoride-containing oral care products. Stannous fluoride gel application was carried out nightly for 5 min according to the manufacturer's instructions. The participants were instructed to place a pea-sized amount of the CPP-ACP or placebo cr eme
on the tooth surfaces of each dental arch using a dry, clean finger and leave undisturbed for 5 min, following which the remaining cr eme was spread throughout the mouth using their tongue for another 2 min. Any excess cr eme was then expectorated. The cr eme application was carried out three times daily, once in the morning, afternoon and at night; with the nightly application carried out 10 min after the stannous fluoride gel application. Participants were advised not to rinse, eat or drink 30 min after each gel or cr eme application. Compliance was monitored by participants keeping a diary of fluoride gel, cr eme and toothpaste and returning used product tubes. Participants also received a weekly reminder call on compliance.
Participants were given a dental prophylaxis before the start of a 7-week treatment of IMRT. They were assessed at five study visits: (i) baseline: after oral health clearance, before radiotherapy, before fluoride and cr eme application (Pre-RT1); (ii) at start of radiotherapy, after 1 week of fluoride and cr eme application (Pre-RT2); (iii) 4 weeks after start of radiotherapy (Mid-RT) (iv) 2 weeks postradiotherapy (Post-RT1) and (v) 12 weeks postradiotherapy (Post-RT2). Study participants were instructed not to brush their teeth 24 h prior to and to refrain from drinking or eating 1 h prior to their study appointments. Resting saliva flow rate measurement and samples were collected according to established protocols. 36 Participants sat in CPP-ACP lowers radiation caries progression a relaxed position with the head tilted slightly forward and expectorated into a preweighed flask for 5 min.
Resting saliva volume was determined gravimetrically, assuming a specific gravity of 1.0 and the flow rate (mL/min) calculated. Saliva sample preparation was prepared for fluoride ion analysis using a fluoride-specific electrode (96-09 Orion Ionplus; Thermo Scientific, MA, USA). The analytical technique for low level fluoride measurement used was the incremental method of known addition for low ionic strength samples with a fluoride concentration of less than 0.38 ppm and was carried out according to manufacturer's instructions (Thermo Scientific). The saliva sample was diluted using deionized distilled water and centrifuged for 10 min at 930 9 g at room temperature. The supernatant was then filtered using 0.45 lm syringe filter (SPD Scientific, Singapore) and the filtrate used for ionic analysis using equal volumes of sample and low-level TISAB.
Caries status of the coronal surfaces was assessed by a trained examiner using the International Caries Detection and Assessment System (ICDAS II) visual criteria, 37 which assigns a score ranging from 0 to 6 based on the severity of the carious lesion. All teeth were cleaned and dried prior to caries assessment which was carried out at baseline and 12-weeks postradiotherapy visits. From the data, surface level transitions were calculated. Lesion progression was recorded when there were transitions to more severe grades of lesions and were given appropriate positive scores.
Statistical analysis
The primary outcome measure of the study was the proportion of coronal surfaces for each participant showing caries progression at 12 weeks postradiotherapy. The secondary outcome measures were saliva flow rate and saliva fluoride ion concentration. Data were statistically analysed using a linear mixed effects model and a two-tailed z-test with adjustment for clustering. 29, 38, 39 Baseline differences in coronal surface proportions for each ICDAS score between the two groups were analysed using the Wilcoxon Rank sum Test. 40 Statistical analyses were performed using SPSS Version 24 (IBM SPSS Statistics for Windows, Armonk, NY, USA).
RESULTS
The demographics and clinical characteristics for the two study groups are shown in Table 1 . All participants were of Chinese ethnicity with no statistically significant age differences between the two study groups. There was no statistical significant difference in the radiation dose received by the two study groups.
Baseline number of tooth surfaces at risk was 1315 surfaces in 12 participants in the placebo group and 1370 surfaces in 12 participants in the CPP-ACP group. There was no statistically significant difference in the baseline level of carious surfaces present at each ICDAS score between the two study groups ( Table 2 ). The highest ICDAS score recorded at baseline was score 3 as any restorative work that was required had been carried out before the start of the study. At 12 weeks postradiotherapy, 11 placebo participants with 1200 surfaces at risk and 11 CPP-ACP participants with 1240 surfaces at risk returned for the study visit. Radiotherapy had a significant effect on resting saliva flow rate in both study groups (P < 0.001 for both) where flow rate declined to nearly 50% of baseline levels mid-way through the radiotherapy treatment before plateauing, followed by another significant drop at 12 weeks postradiotherapy where it fell to around 20% of its baseline level (Table 3) .
There were no statistically significant differences (P > 0.05) in salivary flow rates between the two study groups at any of the time points (Table 3) . Similarly, no statistically significant differences in saliva fluoride ion concentration were observed between the two groups at any of the time points (Table 3) . In both groups, saliva fluoride ion concentration increased significantly postradiotherapy (P < 0.05).
The number of surfaces that exhibited caries progression (transition matrix scores 1-6) at 12 weeks postradiotherapy in each group are presented in Fig. 2 . In the placebo group, 59 (4.9% of total) tooth surfaces in eight participants exhibited caries progression at 12 weeks postradiotherapy: 14 occlusal (5.8%) and 45 smooth (4.7%) surfaces. Only 29 (2.3% of total) tooth surfaces in nine participants CPC Sim et al.
showed caries progression in the CPP-ACP group: three occlusal (1.2%) and 26 smooth (2.3%) surfaces. The CPP-ACP group showed a significant (P < 0.05) 51% reduction in total coronal surfaces caries progression compared with the placebo group (Table 4) .
DISCUSSION
This clinical study demonstrated that the use of the saliva biomimetic CPP-ACP together with SnF 2 /NaF treatment significantly reduced the rate of caries progression in patients undergoing head-and-neck radiotherapy compared with those patients receiving SnF 2 /NaF alone. Radiotherapy in the head-and-neck region involves the salivary glands, resulting in saliva gland hypofunction leading to significant changes to the oral environment. Healthy saliva is a potent natural agent protecting the oral soft tissues from dehydration as well as protecting the teeth from acid challenge. 41 Its anti-caries activity is dependent on four functions: oral cleansing, antibacterial activity, acid buffering and maintenance of a supersaturated environment with respect to tooth mineral (remineralization). 42 In this study, the drop in resting saliva flow rate was not gradual. As the study participants progressed through their radiotherapy treatment, their saliva flow rate dropped and by 12 weeks postradiotherapy was only 20% of the baseline level. This significant decline in resting saliva flow rate would have reduced oral cleansing, acid buffering and remineralization potential to increase caries risk. [43] [44] [45] This increase in caries risk was observed in the present study as more than 75% of the study participants returned at 12 weeks postradiotherapy exhibiting caries progression. Coronal surface caries analysis has been shown to elucidate decay patterns so as to better understand caries risk and to provide greater power to small clinical studies on high-risk patients. 46 The present study showed that the pattern of distribution of coronal Table 3 CPP-ACP lowers radiation caries progression carious surfaces was similar in both study groups with no significant differences between types of tooth surfaces within each group. However, in both groups, a greater proportion of smooth surfaces exhibited caries progression compared with occlusal surfaces. A greater number of the smooth surface lesions occurred on the buccal and palatal/lingual surfaces, surfaces which are normally less susceptible to caries in healthy individuals with normal saliva flow. This decay pattern is consistent with previously published reports on irradiated head-and-neck cancer patients. 15, 17 This highlights the importance of the protective benefit of a normal healthy saliva flow for effective oral cleansing, acid buffering and remineralization. 43 Baseline resting saliva fluoride ion concentrations measured in the present study were within the range of reported values 47 and were not significantly different between the two groups. Both study groups showed an increase in resting saliva fluoride ion concentration during the radiotherapy treatment as resting saliva flow rate started to decrease. This increase could be attributed to the application of SnF 2 /NaF by the study participants in both groups. No significant differences could be detected in saliva fluoride concentrations between the two groups at any of the time points; consistent with both groups receiving the same SnF 2 /NaF regimen.
At 12 weeks postradiotherapy, the placebo group showed a significantly greater progression of carious surfaces compared with the CPP-ACP group. In fact, the CPP-ACP group exhibited a significant 51% reduction in total coronal surfaces that progressed compared with the placebo group 12 weeks postradiotherapy. This anticariogenic activity of the CPP-ACP shown here is consistent with previous clinical trials showing similar activity in individuals with normal saliva function. 25, 28, 29, 48, 49 As in the current study whereby the participants were also using SnF 2 /NaF together with the CPP-ACP the results also support a previous study demonstrating the additive benefit of providing calcium phosphate together with fluoride to promote remineralization of root caries in irradiated head-and-neck cancer patients. 50 However, the current study is the first study using these patients with the saliva biomimetic CPP-ACP demonstrating efficacy on coronal surfaces. The findings also support other studies demonstrating an additive effect of CPP-ACP and fluoride in remineralization. [30] [31] [32] 34, 49 In health, saliva is metastable and supersaturated with respect to enamel mineral and this stability is maintained by saliva proteins such as statherin and other phosphoproteins. 51, 52 This ability of statherin to stabilize calcium and phosphate solutions has been CPC Sim et al.
attributed to the sequence Asp-Ser(P)-Ser(P)-Glu-Glu-. Casein phosphopeptides are biomimetics of statherin, with a greater content of Ser(P) residues particularly in the sequence -Ser(P)-Ile/Leu-Ser(P)-Ser(P)-Ser(P)-Glu-Glu-, making them superior to statherin in their ability to stabilize and deliver calcium, phosphate and fluoride ions. 25, 53 Casein phosphopeptides stabilize calcium, phosphate and fluoride ions to form casein phosphopetide-amorphous calcium fluoride phosphate (CPP-ACFP) nanocomplexes, providing bioavailable ions to maintain high concentration gradients at the tooth surface thereby driving calcium, phosphate and fluoride ions into the carious lesion, promoting remineralization. 25, [28] [29] [30] The casein phosphopeptides of CPP-ACP can also be metabolized by plaque bacteria to produce ammonia and a pH rise 54 and the phosphate ions of CPP-ACFP are predominantly of the form PO 4 3À which have a high acid buffering capacity. This also helps to explain why regular use of CPP-ACP clinically has been observed to significantly increase plaque pH values towards neutrality. [55] [56] [57] [58] Taken together these prior clinical studies demonstrating enhanced remineralization and acid buffering by the saliva biomimetic CPP-ACFP would explain the significantly reduced coronal surface caries progression by CPP-ACFP in irradiated head and neck cancer patients shown in this study.
CONCLUSION
The results of the present study showed that resting saliva flow rate was significantly reduced following radiotherapy of head and neck cancer patients and that the use of CPP-ACP together with SnF 2 /NaF significantly reduced coronal surface caries progression in these patients compared with those using SnF 2 /NaF alone.
